title: Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis.
authors.forename: Lianne
authors.initials: L
authors.lastname: Koens
authors.forename: Nancy J
authors.initials: NJ
authors.lastname: Senff
authors.forename: Maarten H
authors.initials: MH
authors.lastname: Vermeer
authors.forename: H Karel
authors.initials: HK
authors.lastname: Ronday
authors.forename: Rein
authors.initials: R
authors.lastname: Willemze
authors.forename: Patty M
authors.initials: PM
authors.lastname: Jansen
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001706:Biopsy; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000009:adverse effects*; D016410:Lymphoma, T-Cell, Cutaneous / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept